NBIX

Neurocrine Biosciences
D

NBIX

132.010
USD
0.58
(0.44%)
مغلق
حجم التداول
0
الربح لكل سهم
5
العائد الربحي
-
P/E
45
حجم السوق
13,064,477,898
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
A
ARWR
-0.520
(-3.20%)
15.740 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
ILMN
ILMN
1.730
(1.61%)
109.330 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
S
SGMO
-0.01190
(-1.99%)
0.58600 USD
S
SRPT
-0.970
(-7.53%)
11.910 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.